Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
15.01
+0.17 (1.15%)
At close: Jan 23, 2026
Shenzhen YHLO Biotech Company Description
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally.
The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer.
The company was founded in 2008 and is headquartered in Shenzhen, China.
Shenzhen YHLO Biotech Co., Ltd.
| Country | China |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,678 |
| CEO | Yongbo Song |
Contact Details
Address: Building 1, Baolong, 2nd Road Shenzhen, 518116 China | |
| Phone | 86 755 2660 1910 |
| Website | szyhlo.com |
Stock Details
| Ticker Symbol | 688575 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005204 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Yongbo Song | GM and Vice Chairman of the Board |
| Lisheng Liao | Chief Financial Officer and Director |
| Yujing Xiao | Deputy General Manager |
| Chun Gen Qian | Deputy GM and Director |
| Mingyang Wang | Secretary of the Board |